Chitogast 60 Boston treats symptoms of acute and chronic osteoarthritis (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Etoricoxib
Ingredient Ischemic anemia, liver failure, kidney failure, intestinal disorders, digestive ulcers, drug allergies, heart failure

Ingredient

Composition informationContent
Etoricoxib60mg

Uses

indications

chitogast drugs are indicated in the following cases:

  • Treatment of symptoms of acute and chronic osteoarthritis. High filter for COX - 2 inhibition. Cycloxygevaase (COX - 2) concentration at inflamed tissues leads to the synthesis of Prostaglandins is the intermediate substance of the pain and inflammation process. The mechanism of action of Etorieoxib is thought to be due to inhibition of the synthesis of protaglandins mainly through COX - 2. In the concentrations of treatment in human plasma, Etoricoxib does not inhibit COX - 1.

    Dynamic pharmacokinetics

    Etorieoxib orally reach 100% biological and time to reach the peak concentration in plasma is an hour. About 90% of protein -mounted drugs do not cause significant changes in the level and absorption speed when used with food. Etorieoxib is metabolized mainly in the liver by Cytochrome P450 (CYP) - 3A4 and is excreted in the urine, mainly in the form of metabolites in which no metabolites have a significant Cox - 2 or COX - 1 inhibitor. Etoricoxib's waste sale time is 22 hours.

  • Before taking Chitogast 60 Boston treats symptoms of acute and chronic osteoarthritis (3 blisters x 10 tablets)

    How to use

    oral, oral or after meals.

    Dosage

    Adults

  • Osteoarthritis: 30 mg/time/day. Increase dose 60 mg/day/day if symptoms do not decrease.
  • Rheumatoid arthritis, stiff spondylitis: 90 mg/day/day.
  • Acute arthritis due to gout: 120 mg/day/day, use up to 8 days.
  • Chronic analgesic: 60 mg/day/day.
  • Acute analgesic, abolished dysmenorrhea: 120 mg/day/day.
  • Children and adolescents

  • It is not recommended if under 16 years old.
  • Patients with mild liver failure: 60 mg/day/day.
  • Patients with medium liver failure: 30 mg/day/day.
  • Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

    do when using overdose?

    What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

    Side Effects

    When using Chitogast, you may experience unwanted effects (ADR).

  • On the nervous system: taste disorders, blurred vision, restless anxiety, insomnia or sleeping, hallucinations ...
  • On the circulatory system: platelet reduction, congestion heart failure, brushing chest, angina, tachycardia, drama hypertension ...

  • On the respiratory system: bronchial spasm.
  • On the digestive system: abdominal pain, gastrointestinal ulcer, nausea, diarrhea, jaundice ...

  • On the urinary system: Disability of kidney, including renal failure.
  • The immune and metabolic system: hypersensitivity reactions, anaphylactic reactions, hyperkalemia.

    In addition, it can cause: itching, urticaria, erythema, angio ...

    Instructions on how to handle ADR

    Notify the doctor with unwanted effects when using the drug.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Chitogast drug contraindicated in the following cases:

  • Patients with hypersensitivity to Etoricoxib or any ingredients of the drug.
  • Patients with gastrointestinal ulcers or acute gastrointestinal bleeding.
  • Patients with severe liver failure or creatinine clearance is lower than 30 ml/min.

  • Patients with severe intestinal diseases and congestive heart failure.
  • Ischemic heart disease, peripheral artery disease, brain vascular disease have been identified.

  • Children and adolescents under 16 years old.
  • Pregnant and lactating women.

    Be cautious when used

    Use cautiously in patients with significant risk factors for cardiovascular events (such as hypertension, diabetes, hyperlipidemia, smoking ...).

    When treated with Etoricoxib, especially at high doses, regular blood pressure monitoring and if the blood pressure increases significantly, it is necessary to replace other treatment directions because Etoricoxib can coordinate with more frequent and serious hypertension than some NSAIDs and other COX -2 selective inhibitors.

    Use Etoricoxib cautiously with patients with significant dehydration and should rehydration before use.

    Need to use carefully anti -hypertension drugs when the patient shows signs of heart failure, impaired left ventricular function and previous edema.

    For patients with liver, kidney or heart dysfunction and elderly patients must be closely monitored and when there is a worsening manifestation, they must take appropriate handling measures immediately including stopping treatment with this drug.

    Use cautiously Eoricoxib in patients with a history of perforation, ulcers, gastrointestinal bleeding and patients over 65 years old.

    The ability to drive and operate machinery

    After taking the patient's medicine, the patient may be dizzy and drowsy, so limit driving and operating machinery.

    Pregnancy

    Contraindications for pregnant women.

    Lactation period

    Contraindications for breastfeeding women.

    Drug interaction

    Warfarin: In patients who have been treated stably with warfarin, using Etoricoxib 120 mg daily can lead to an increase of about 13% of prothrombin compared to international standard ratios (INR). The Inr price strict control should be strictly controlled when starting with Etoricoxib, especially in the first days, when the patient is using Warfarin or the same substances.

    Rifampin: Concomitant use of Etoricoxib with rifampin, a agent capable of causing metabolic enzyme induction in strong liver, reducing 65% of the area under the curve (AUC) in the plasma of Etoricoxib. This interaction should be taken into account when Etoricoxib is used with rifampin.

    methotrexate: Methotrexate toxicity monitoring should be monitored when used simultaneously Etoricoxib at a dose of 90 mg daily and methotrexate.

    Angiotensin (ACE) inhibitors: There have been reports on acknowledging non -selective NSAIDs inhibitors and selective Cox - 2 inhibitors can reduce the anti -hypertension effect of ACE inhibitors.

    Lithium: There has been a report that acknowledges the non -selective NSAIDs inhibitors and COX - 2 inhibitors can increase plasma lithium concentration.

    Aspirin: Concomitant use of low -dose aspirin with Etoricoxib can lead to the increase in gastrointestinal ulcers and other complications compared to the case of Etoricoxib only.

    Oral oral medications: Etoricoxib treated with a dose of 120 mg with a oral drug to avoid 35 mcg ethinyl estradiol (EE) and 0.5 to 1 mg norethindrone for 21 days, simultaneous use or 12 hours apart, increasing AUC0 - 24 hours in the stable state of EE to 50 to 60%.

    Other drugs: Etoricoxib does not have an important clinical effect on the pharmacokinetics of Prednisone/Prednisolone or Digoxin.

    Storage

    In closed packaging, dry place, less than 300C, avoid light.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords